Table 3 Regular prescription drugs change between baseline and the 1-year follow up
| Number of participants, n (%) | ||||
|---|---|---|---|---|
| Intervention group | Control group | |||
| n = 22 | n = 18 | |||
| Antihypertensive drugs | ||||
| Increase | 1 | (5) | 5 | (28) |
| Stable | 21 | (95) | 13 | (72) |
| Decrease | 0 | 0 | ||
| Lipid-lowering drug | ||||
| Increase | 3 | (14) | 1 | (6) |
| Stable | 19 | (86) | 17 | (94) |
| Decrease | 0 | 0 | ||
| Anti-diabetic | ||||
| Increase | 0 | 1 | (6) | |
| Stable | 22 | (100) | 16 | (88) |
| Decrease | 0 | 1 | (6) | |